BCL6B expression in hepatocellular carcinoma and its efficacy in the inhibition of liver damage and fibrogenesis-Reference-Cited by-同舟云学术

BCL6B expression in hepatocellular carcinoma and its efficacy in the inhibition of liver damage and fibrogenesis

Published:2015-04-27 Issue:24 Volume:6 Page:20252-20265
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wang Weilin¹²³,Huang Pengfei¹³,Wu Panyisha²³,Kong Rong¹,Xu Jiang¹,Zhang Lufei¹,Yang Qifan¹,Xie Qingsong¹,Zhang Linshi²,Zhou Xiaohu¹,Chen Linghui¹,Xie Haiyang¹³,Zhou Lin¹³,Zheng Shusen¹²³

Affiliation:

1. Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou 310003, China

2. Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China

3. Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou 310003, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BCL6B-dependent suppression of ETV2 hampers endothelial cell differentiation;Stem Cell Research & Therapy;2024-07-29

2. BCL6B-dependent Suppression of ETV2 Hampers Endothelial Cell Differentiation;2024-02-28

3. A pan-cancer analysis of TNFAIP8L1 in human tumors;Medicine;2023-12-08

4. ZBTB28 inhibits breast cancer by activating IFNAR and dual blocking CD24 and CD47 to enhance macrophages phagocytosis;Cellular and Molecular Life Sciences;2022-01-20

5. BCL6B hypermethylation predicts metastasis and poor prognosis in early-stage hepatocellular carcinoma after thermal ablation;Journal of Cancer Research and Therapeutics;2021